logo-loader
Arcadia Biosciences Inc

Shares of Arcadia Biosciences jump after White House streamlines approval process of new GMO crops

President Trump on Tuesday signed an executive order instructing the Agriculture Department, the FDA and the EPA to ease rules for GMO crops and other agricultural biotechnology

crops
California-based Arcadia produces a GMO soybean

Shares of Arcadia Biosciences Inc (NASDAQ:RKDA) increased by double-digits Wednesday after the Trump administration ordered three federal agencies to ease their rules for approving genetically modified crops and other agricultural biotechnology.

President Trump on Tuesday signed an executive order instructing the Agriculture Department, the Food and Drug Administration and the Environmental Protection Agency — which oversee genetically engineered agricultural products — to review their biotech regulations to streamline the approval processes.

Arcadia, based in Davis, California, is an agricultural biotech company that develops high-value food ingredients and nutritional oils that aim to meet the demand for healthier diets. It also produces a GMO soybean.

The company’s stock closed up 19.6% to $5.91 a share.

READ: Arcadia Biosciences rapidly advances cannabis business as it reports first-quarter highlights

The White House wants to bring new agricultural biotechnology to the marketplace faster and with less cost for companies. Also the Trump administration hopes to encourage more investment in GMO crops.

Trump’s executive order comes after the US Agriculture Department last week proposed sweeping changes to biotech rules that would exempt from regulation genetically edited farm products with traits “similar in kind” to modifications that could be produced through traditional breeding techniques.

Arcadia operates in specialty genomics and has a proprietary approach combining conventional breeding and gene editing.

And on Friday the US told the World Trade Organization that it was planning to revise its regulations on importing, transporting and releasing GMOs.

“As a leading U.S. crop improvement company, Arcadia Biosciences is focused on enhancing the nutritional value and quality of food ingredients while improving crop productivity to allow America’s agricultural industry to be more sustainable and prosperous," a company spokesperson said. "We’re supportive of any legislation that fosters public confidence in science-based crop innovation and streamlines regulatory approaches in order to reduce undue financial and logistical burdens on farmers.”

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: Arcadia Biosciences Inc

Price: $5.30

Market: NASDAQ
Market Cap: $38.68 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

on 08/16/2019

2 min read